Cancer centers and high-volume hospitals may examine more lymph nodes in cancer patientsJuly 22, 2008Patients with gastric or pancreatic cancer appear to have more lymph nodes examined for the spread of their disease if they are treated at hospitals performing more cancer surgeries or those designated as comprehensive cancer centers, according to a report in the July issue of Archives of Surgery, one of the JAMA/Archives journals. Lymph node metastases (indicating the spread of cancer) have been shown to predict patients' prognosis after cancer tissue is removed from the stomach or pancreas, according to background information in the article. If too few lymph nodes are examined for malignant cells, a patient's cancer may be incorrectly classified, altering prognosis, treatment decisions and eligibility for clinical trials. "Although the precise number varies, current guidelines recommend resection and pathologic evaluation of at least 15 regional lymph nodes for gastric and pancreatic cancer," the authors write. Karl Y. Bilimoria, M.D., M.S., of the American College of Surgeons and Feinberg School of Medicine, Northwestern University, Chicago, and colleagues used records from the National Cancer Data Base (NCDB) to identify patients who had surgery for gastric or pancreatic cancer that was diagnosed in 2003 or 2004. Hospitals at which patients had surgery were classified based on case volume and also based on access to cancer-related services and specialists.
Of 3,088 patients with gastric cancer, 11.6 percent had surgery at a hospital designated as a National Cancer Institute (NCI) comprehensive cancer center or as part of the National Comprehensive Cancer Network (NCCN-NCI hospitals), 34 percent at other academic hospitals (affiliated with a medical school but not designated as NCCN-NCI facilities) and 54.4 percent at community hospitals. Nineteen percent of 1,130 pancreatic cancer patients had surgery at NCCN-NCI hospitals, 43.3 percent at other academic hospitals and 37.7 percent at community hospitals. "Patients undergoing surgery had more lymph nodes examined at NCCN-NCI hospitals than at community hospitals (median [midpoint], 12 vs. six for gastric cancer and nine vs. six for pancreatic cancer)," the authors write. "Patients at highest-volume hospitals had more lymph nodes examined than patients at low-volume hospitals (median, 10 vs. six for gastric cancer and eight vs. six for pancreatic cancer)." Overall, 23.2 percent of patients with gastric cancer and 16.4 percent of patients with pancreatic cancer had at least 15 lymph nodes evaluated. Patients at high-volume or NCCN-NCI hospitals were more likely to have at least 15 lymph nodes evaluated than patients undergoing surgery at community or low-volume hospitals. "Nodal status is a powerful predictor of outcome, and every reasonable attempt should be made to assess the optimal number of lymph nodes to accurately stage disease in patients with gastric and pancreatic cancer," the authors write. "Moreover, differences in nodal evaluation may contribute to improved long-term outcomes at NCCN-NCI centers and high-volume hospitals for patients with gastric and pancreatic cancer." JAMA and Archives Journals | |||||||||||||||||||||
|
Related Lymph Nodes News Articles Bone marrow stem cells may help control inflammatory bowel disease Massachusetts General Hospital (MGH) investigators have found that infusions of a particular bone marrow stem cell appeared to protect gastrointestinal tissue from autoimmune attack in a mouse model. Bowel cancer indicator should lead to better treatment STEM cell scientists have developed a more accurate way of identifying aggressive forms of bowel cancer, which should eventually lead to better treatment and survival rates. Stem cell indicator for bowel cancer should lead to better survival rates Stem cell scientists have developed a more accurate way of identifying aggressive forms of bowel cancer, which should eventually lead to better treatment and survival rates. Bowel cancer is the third most common cancer in the UK. Prototype test for predicting clinical outcome for melanoma patients Investigators from the Melbourne Center of the international Ludwig Institute for Cancer Research (LICR) and Pacific Edge Biotchnology Ltd today reported that they have developed a test to predict whether a patient will progress rapidly from Stage III melanoma to metastatic Stage IV cancer and death. Trapping white blood cells proves novel strategy against chronic viral infections Seeing disease-fighting white blood cells vanish from the blood usually signals a weakened immune system. But preventing white blood cells' circulation by trapping them in the lymph nodes can help mice get rid of a chronic viral infection, researchers at Yerkes National Primate Research Center and the Emory Vaccine Center have found. Trapping white blood cells proves novel strategy against chronic viral infections Seeing disease-fighting white blood cells vanish from the blood usually signals a weakened immune system. But preventing white blood cells' circulation by trapping them in the lymph nodes can help mice get rid of a chronic viral infection, researchers at Yerkes National Primate Research Center and the Emory Vaccine Center have found. U of M study shows why treatment isn't effective for HIV University of Minnesota researchers have answered a key question as to why antiretroviral therapy isn't effective in restoring immunity in HIV-infected patients. Checking more lymph nodes linked to cancer patient survival Why do patients with gastric or pancreatic cancer live longer when they are treated at cancer centers or high-volume hospitals than patients treated at low-volume or community hospitals? MDCT, virtual gastroscopy and MPR images differentiate malignant and benign gastric ulcers Multidetector CT using virtual gastroscopy and post contrast enhanced multiplanar reformation images can be useful in differentiating between malignant and benign gastric ulcers, according to a recent study conducted by researchers from Kaohsiung Medical University Hospital in Kaohsiung, Taiwan. Improving understanding of cell behaviour in breast cancer The invasion and spread of cancer cells to other parts of the body, known as metastasis, is a principal cause of death in patients diagnosed with breast cancer. More Lymph Nodes News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||